Michael G. Fradley

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Syed Mahmood, Michael G. Fradley, Justine V. Cohen et al. · Journal of the American College of Cardiology · 2018 · 1.5K citations · Full text

Heart Failure, Autoimmune Disease, Immune Checkpoint Inhibitors +7

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley et al. · Annals of Oncology · 2020 · 950 citations · Full text

Oncology, Cardiovascular Disease, Cardiac Disease +11

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Susan Dent, Susannah Stanway et al. · European Journal of Heart Failure · 2020 · 717 citations · Full text

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian et al. · European Heart Journal · 2021 · 542 citations · Full text

Heart Failure, Oncology, Cardiovascular Toxicities +15

Prognostic Utility of Novel Biomarkers of Cardiovascular Stress

Thomas J. Wang, Kai C. Wollert, Martin G. Larson et al. · Circulation · 2012 · 469 citations · Full text